Antiviral evaluation of octadecyloxyethyl esters of (S)-3-hydroxy-2-(phosphonomethoxy)propyl nucleosides against herpesviruses and orthopoxviruses.

Antiviral evaluation of octadecyloxyethyl esters of (S)-3-hydroxy-2-(phosphonomethoxy)propyl nucleosides against herpesviruses and orthopoxviruses.
复制标题

DOI:
10.1016/j.antiviral.2009.09.012
复制
发表时间:
2009-12
期刊:
影响因子:
7.6
通讯作者:
Hostetler, Karl Y.
Hostetler, Karl Y.
中科院分区:
医学2区
文献类型:
--
作者:
Valiaeva, Nadejda;Prichard, Mark N.;Buller, R. Mark;Beadle, James R.;Hartline, Caroll B.;Keith, Kathy A.;Schriewer, Jill;Trahan, Julissa;Hostetler, Karl Y.

文献摘要

参考文献

被引文献

相似文献

我们的前期研究表明,(S)-3-羟基-2-(膦酰甲氧基)丙基]腺嘌呤(HPMPA)或1-(S)-[3-羟基-2-(膦酰甲氧基)丙基]胞嘧啶(HPMPC)与烷氧基烷基如十六烷氧基丙基(HDP)或十八烷氧基乙基(ODE)的酯化可显著提高抗病毒活性和口服生物利用度。HPMPA的HDP-和ODE-酯在感染人类免疫缺陷病毒1型(HIV-1)的细胞中显示出活性,而HPMPA本身实际上无活性。为了更详细地探索这种方法,我们合成了该系列中的四个新化合物,9-(S)-[3-羟基-2-(3-羟基-2-甲基苯基)-2-(4-羟基苯基(膦酰甲氧基)-丙基]鸟嘌呤(HPMPG),1-(S)-[3-羟基-2-(膦酰基-甲氧基)丙基]胸腺嘧啶(HPMPT),9-(S)-[3-羟基-2-(膦酰甲氧基)丙基]-2,6-二氨基嘌呤(HPMPDAP)和9-(S)-[3-羟基-2-(膦酰甲氧基)丙基]-2-氨基-6-环丙基氨基嘌呤。(HPMP-cPrDAP),并评估它们对单纯疱疹病毒1型(HSV-1)、人巨细胞病毒(HCMV)以及牛痘、牛痘和肢脱病的抗病毒活性。对于HSV-1,用ODE-HPMPA和ODE-HPMPC观察到亚纳摩尔EC 50值,而ODE-HPMPG具有中等抗病毒活性,EC 50为40纳摩尔。在感染HCMV的HFF细胞中,ODE-HPMPC的EC 50值最低,为0.9纳摩尔。ODE-HPMPA具有高活性,EC 50为3纳摩尔,而ODE-HPMPG和ODE-HPMPDAP也具有高活性,EC 50分别为22和77纳摩尔。针对牛痘和牛痘病毒,ODE-HPMPG和ODE-HPMPDAP是最具活性和选择性的化合物,EC 50值为20至60纳摩尔,选择性指数值为600至3,500。ODE-HPMPG对鼠痘病毒也有活性,EC 50值为410纳摩尔,选择性指数值为166。ODE-HPMPG和ODE-HPMPDAP被提议作为治疗HSV、HCMV或正痘病毒疾病的可能候选物用于进一步的临床前评价。
Our previous studies showed that esterification of (S)-3-hydroxy-2-(phosphono-methoxy)propyl]adenine (HPMPA) or 1-(S)-[3-hydroxy-2-(phosphonomethoxy)-propyl]cytosine (HPMPC) with alkoxyalkyl groups such as hexadecyloxypropyl (HDP) or octadecyloxyethyl (ODE) resulted in large increases in antiviral activity and oral bioavailability. The HDP- and ODE- esters of HPMPA were shown to be active in cells infected with human immunodeficiency virus, type 1 (HIV-1), while HPMPA itself was virtually inactive. To explore this approach in greater detail, we synthesized four new compounds in this series, the ODE esters of 9-(S)-[3-hydroxy-2-(phosphonomethoxy)-propyl]guanine (HPMPG), 1-(S)-[3-hydroxy-2-(phosphono-methoxy)propyl]thymine (HPMPT), 9-(S)-[3-hydroxy-2-(phosphonomethoxy)propyl]-2,6-diaminopurine (HPMPDAP) and 9-(S)-[3-hydroxy-2-(phosphonomethoxy)propyl]-2-amino-6-cyclopropylaminopurine. (HPMP-cPrDAP) and evaluated their antiviral activity against herpes simplex virus, type 1 (HSV-1), human cytomegalovirus (HCMV), and vaccinia, cowpox and ectromelia. Against HSV-1, subnanomolar EC50 values were observed with ODE-HPMPA and ODE-HPMPC while ODE-HPMPG had intermediate antiviral activity with an EC50 of 40 nanomolar. In HFF cells infected with HCMV, the lowest EC50 values were observed with ODE-HPMPC, 0.9 nanomolar. ODE -HPMPA was highly active with an EC50 of 3 nanomolar, while ODE-HPMPG and ODE-HPMPDAP were also highly active with EC50s of 22 and 77 nanomolar, respectively. Against vaccinia and cowpox viruses, ODE-HPMPG and ODE-HPMPDAP were the most active and selective compounds with EC50 values of 20 to 60 nanomolar and selectivity index values of 600 to 3,500. ODE-HPMPG was also active against ectromelia virus with an EC50 value of 410 nanomolar and a selectivity index value of 166. ODE-HPMPG and ODE-HPMPDAP are proposed for further preclinical evaluation as possible candidates for treatment of HSV, HCMV or orthopoxvirus diseases.
DOI: 10.1124/mol.63.3.678
发表时间: 2003-03-01
影响因子: 3.6
作者:
Aldern, KA;Ciesla, SL;Hostetler, KY
通讯作者: Hostetler, KY
DOI: 10.1128/aac.01172-07
发表时间: 2008-02-01
影响因子: 4.9
作者:
Magee, Wendy C.;Aldern, Kathy A.;Evans, David H.
通讯作者: Evans, David H.
DOI: 10.1128/aac.00444-06
发表时间: 2007-02-01
影响因子: 4.9
作者:
Choo, Hyunah;Beadle, James R.;Hostetler, Karl Y.
通讯作者: Hostetler, Karl Y.
DOI: 10.1021/jm050473m
发表时间: 2006-03-23
影响因子: 7.3
作者:
Beadle, JR;Wan, WB;Hostetler, KY
通讯作者: Hostetler, KY
DOI: 10.1128/aac.49.8.3153-3162.2005
发表时间: 2005-08-01
影响因子: 4.9
作者:
Magee, WC;Hostetler, KY;Evans, DH
通讯作者: Evans, DH